MYC and pancreatic neoplasm: Notably, glutamine reportedly stabilizes c‐MYC via α‐ketoglutarate to prevent c‐MYC degradation through the ubiquitination–proteosomal pathway, thus weakening the sensitivity of pancreatic cancer cells to paclitaxel.49